Raymond CF Tong - Aug 10, 2021 Form 3 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role: Director
Signature: /s/ Raymond C.K. Tong
Stock symbol: PMCB
Transactions as of: Aug 10, 2021
Transactions value $: $0
Form type: 3
Date filed: 8/20/2021, 08:36 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PMCB	Common Stock						1.33K	Aug 10, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PMCB	Stock Option (right to buy)							Aug 10, 2021	Common Stock	334	$82.95	Direct	F1, F2
holding	PMCB	Stock Option (right to buy)							Aug 10, 2021	Common Stock	334	$97.35	Direct	F1, F2
holding	PMCB	Stock Option (right to buy)							Aug 10, 2021	Common Stock	334	$51.00	Direct	F1, F2
holding	PMCB	Stock Option (right to buy)							Aug 10, 2021	Common Stock	334	$15.57	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021 (the "Reverse Split").
F2	The exercise price has been adjusted to reflect the Reverse Split.